The Use of STOPP/START Criteria for Medication Intervention and the Risk of Falls, Hospitalization, Functioning and Quality of Life Among Elderly Population Living in a Geriatric Hospital in Israel and Comparison to Beers
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 382
- 试验地点
- 2
- 主要终点
- Quality of Life- Mental Component Summaty (MCS)
研究概览
简要总结
The purpose of this study is to determine if the use of STOPP/START criteria (STOPP-screening tool of older persons potentially inappropriate prescriptions START-screening tool to alert doctors to right treatment)for medication intervention in elderly population living in a geriatric hospital will lower the number of falls,hospitalization,will improve functioning, quality of life and reduce financial costs.
详细描述
Inappropriate prescribing is common in older people and is associated with adverse drug effects,hospitalization and falls. In this trial we want to check the efficacy of the screening tools STOPP/START which were developed and validated in order to reduce inappropriate prescribing. STOPP comprises of 65 indicators of drug-drug, drug-disease interactions and therapeutic duplication. START incorporates 22 evidence based indicators of common prescribing omissions. We will conduct a randomized controlled trial to test the hypothesis that screening the medications of older patients living permanently in a geriatric hospital will improve their quality of life. The compliance of the doctor working in the geriatric hospital to the recommendations of the screening tools will also be checked.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Screening
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age over 65
- •live in the geriatric hospital "Givaat Hashlosha" permanently.
排除标准
- •people with a terminal illness that will not live more than a year.
- •people who enter the geriatric hospital for a short while (are not permanent).
研究组 & 干预措施
Controll
The medications in this arm will not be screened.
Intervention screening medication group
STOPP/START screening tools are used for medication intervention
干预措施: STOPP/START screening tools for medication intervention (Other)
结局指标
主要结局
Quality of Life- Mental Component Summaty (MCS)
时间窗: Outcome measures were assessed at the end of the 12 month follow up
Quality of life will be measured by MOS SF-12 Health Survey questionnare. Results are expressed in terms of two meta scores: The Physical Component Summary(PCS) and the Mental Component Summary (MCS). The PCS and MCS scores have a range of 0 to 100, thus scores greater than 50 represent a better than average health status.
Falls
时间窗: At the end of the 12 month follow up
Average number of falls per year.
Hospitalizations
时间窗: Outcome measures were assessed at the end of the 12 month follow up
The average number of hospitalizations per year.
SF-12 Health Survey questionnaire-the Physical Component Summary (PCS)
时间窗: Outcome measures were assessed at the end of the 12 month follow up
Quality of life was assessed by the SF-12 Health Survey questionnare. Results are expressed in terms of two meta scores:the Physical Component Summary (PCS) AND Mental Component Summary (MCS). The PCS and MCS scores have a range of 0 to 100, thus scores greater than 50 represent a better than average health status.
Functional Independence Measure (FIM)
时间窗: Outcome measures were assessed at the end of the 12 month follow up
Functioning was assessed by the FIM score. The FIM rates 18 activities of daily living on a 7 point scale ranging from fully dependent (=1) to independent (=7). A maximum score of 126 indicates functional independence and the lowest score of 18 indicates functional dependence.
次要结局
- Pharmacoeconomics Analysis-Costs of Medication(Outcome measures were assessed at the end of the 12 month follow up)